EUCRATES BIOMEDICAL ACQU COR - UNIT 10/23/2027 (EUCRU)

CUSIP: G3141W114

Q2 2021 13F Holders as of 30 Jun 2021

Type / Class
Equity / UNIT 10/23/2027
Total 13F shares
4,266,479
Share change
-794,150
Total reported value
$43,488,000
Price per share
$10.20
Number of holders
18
Value change
-$7,987,379
Number of buys
2
Number of sells
10

Quarterly Holders Quick Answers

What is CUSIP G3141W114?
CUSIP G3141W114 identifies EUCRU - EUCRATES BIOMEDICAL ACQU COR - UNIT 10/23/2027 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of EUCRATES BIOMEDICAL ACQU COR - UNIT 10/23/2027 (EUCRU) as of Q2 2021

As of 30 Jun 2021, EUCRATES BIOMEDICAL ACQU COR - UNIT 10/23/2027 (EUCRU) was held by 18 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 4,266,479 shares. The largest 10 holders included DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), PRICE T ROWE ASSOCIATES INC /MD/, BVF INC/IL, Magnetar Financial LLC, Verition Fund Management LLC, Sio Capital Management, LLC, HealthCor Management, L.P., Rock Springs Capital Management LP, Wealthspring Capital LLC, and Sage Mountain Advisors LLC. This page lists 18 institutional shareholders reporting positions in this security for the Q2 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.